Zhe Xu

13.8k total citations · 1 hit paper
84 papers, 7.4k citations indexed

About

Zhe Xu is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Zhe Xu has authored 84 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 19 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Zhe Xu's work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (6 papers) and Liver Disease and Transplantation (6 papers). Zhe Xu is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (6 papers) and Liver Disease and Transplantation (6 papers). Zhe Xu collaborates with scholars based in China, United States and France. Zhe Xu's co-authors include Fu‐Sheng Wang, Peng Zhao, Lei Shi, Chao Zhang, Jin‐Wen Song, Hongxia Liu, Jinghui Dong, Shuhong Liu, Tingting Gao and Yanhong Tai and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Zhe Xu

76 papers receiving 7.2k citations

Hit Papers

Pathological findings of COVID-19 associated with acute r... 2020 2026 2022 2024 2020 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhe Xu China 24 4.7k 2.4k 969 920 741 84 7.4k
Yanhong Tai China 22 4.4k 1.0× 2.4k 1.0× 1.0k 1.0× 1.2k 1.3× 857 1.2× 46 7.2k
Li Zhu China 16 4.6k 1.0× 2.4k 1.0× 778 0.8× 804 0.9× 687 0.9× 54 7.0k
Jin‐Wen Song China 17 4.5k 1.0× 2.4k 1.0× 749 0.8× 896 1.0× 633 0.9× 63 6.9k
Peng Xia China 23 4.5k 1.0× 2.4k 1.0× 746 0.8× 1.2k 1.3× 689 0.9× 103 7.6k
Changqing Bai China 20 4.6k 1.0× 2.4k 1.0× 690 0.7× 959 1.0× 674 0.9× 44 7.0k
Yijin Wang China 17 4.5k 1.0× 2.4k 1.0× 749 0.8× 760 0.8× 655 0.9× 52 6.7k
Hongxia Liu China 23 4.4k 1.0× 2.4k 1.0× 824 0.9× 1.4k 1.5× 883 1.2× 84 7.6k
Jinghui Dong China 12 4.7k 1.0× 2.5k 1.0× 1.0k 1.1× 707 0.8× 679 0.9× 39 6.9k
Yadong Gao China 26 4.1k 0.9× 2.0k 0.8× 923 1.0× 672 0.7× 646 0.9× 91 6.8k

Countries citing papers authored by Zhe Xu

Since Specialization
Citations

This map shows the geographic impact of Zhe Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Xu more than expected).

Fields of papers citing papers by Zhe Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Xu. The network helps show where Zhe Xu may publish in the future.

Co-authorship network of co-authors of Zhe Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Xu. A scholar is included among the top collaborators of Zhe Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Xu. Zhe Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Siyu, Tao Yang, Tiantian Li, et al.. (2025). Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation. Chinese Medical Journal. 138(22). 2984–2992. 1 indexed citations
2.
Xiao, Mengmeng, Zhe Xu, Jingtao Hu, et al.. (2025). Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by enzyme activity-dependent and direct interaction with nucleocapsid protein. Journal of Virology. 99(5). e0042825–e0042825.
3.
Zheng, Xu, Zhe Xu, Xing Fan, et al.. (2025). Antioxidant interventions reduced cytokine-induced pyroptosis of peripheral MAIT cells in patients with HBV-related cirrhosis. Hepatology Communications. 9(6). 1 indexed citations
6.
Zhang, Xu, et al.. (2024). The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice. Molecular Therapy. 32(7). 2176–2189. 6 indexed citations
7.
Huang, Furong, Fang Li, Yufeng Xing, et al.. (2024). From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients. Frontiers in Microbiology. 15. 1366744–1366744. 11 indexed citations
8.
Zhao, Min, Enqiang Qin, Dawei Zhang, et al.. (2020). Expert consensus on clinical prevention and treatment of COVID-19. Jiefangjun yixue zazhi. 45(11). 1109–1116. 2 indexed citations
9.
Wu, Zhenfeng, Kun Zou, Guannan Wu, et al.. (2020). A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients. Digestive Diseases and Sciences. 66(5). 1673–1682. 36 indexed citations
10.
Tu, Bo, Jingfeng Bi, Zhe Xu, et al.. (2020). Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis. World Journal of Gastroenterology. 26(29). 4316–4326. 4 indexed citations
11.
Huang, Lei, Jijing Shi, Yan‐Mei Jiao, et al.. (2019). Skewed CD39/CD73/adenosine pathway in B cells is associated with innate immune hyperactivation in chronic HIV-1 infection. SHILAP Revista de lepidopterología. 4(1). 9 indexed citations
12.
Li, Xiaokun, Qing‐Bin Lu, Weiwei Chen, et al.. (2018). Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Science Translational Medicine. 10(459). 67 indexed citations
13.
Xu, Zhe, Shaojun Xing, Qiang Shan, et al.. (2017). Cutting Edge: β-Catenin–Interacting Tcf1 Isoforms Are Essential for Thymocyte Survival but Dispensable for Thymic Maturation Transitions. The Journal of Immunology. 198(9). 3404–3409. 25 indexed citations
14.
15.
Xu, Zhe, Bo Jin, Guangju Teng, et al.. (2016). Epidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone. American Journal of Infection Control. 44(11). 1285–1290. 17 indexed citations
16.
Zhang, Xin, Yihui Rong, Li Liu, et al.. (2015). Prognostic Analysis of Patients with Ebola Virus Disease. PLoS neglected tropical diseases. 9(9). e0004113–e0004113. 18 indexed citations
17.
Zhang, Jianzhong, et al.. (2012). The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B. Clinical & Experimental Immunology. 171(3). 307–312. 6 indexed citations
18.
Wu, Xiaoyu, Gang Li, Zhe Xu, et al.. (2006). Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy. European Journal of Cancer. 42(7). 888–894. 23 indexed citations
19.
Liu, Fukun, Che Chen, Xiao-Ping Qi, Zhe Xu, & Jieshou Li. (2005). [Effect of preoperative radiotherapy as an adjunctive approach on proliferation and apoptosis of cancer cells in rectal cancer].. PubMed. 8(1). 71–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026